Insider Transactions Reported by 7 Insiders of PRESSURE BIOSCIENCES INC

Location
Canton, MA

Key facts

  • PRESSURE BIOSCIENCES INC has 7 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are not currently available.

Change

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Research use

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 24 May 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

PRESSURE BIOSCIENCES INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Kevin Pollack Director $5,886 Mixed 27 Mar 2024
Jeffrey N. Peterson Director $3,978 Mixed 27 Sep 2024
Vito J. Mangiardi Director $2,577 Mixed 27 Mar 2024
Schumacher Richard T. President, CEO, Director $2,323 Mixed 27 Sep 2024
Michael S. Urdea Director $1,332 Mixed 27 Sep 2024
Alexander V Lazarev Director $1,047 Mixed 27 Sep 2024
Edmund Y. Ting Senior VP of Engineering Mixed 18 Oct 2023

Top shareholders of PRESSURE BIOSCIENCES INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Kevin Pollack
3/4/5
Director
mixed-class rows
341,850
mixed-class rows
$5,886 27 Mar 2024
Jeffrey N. Peterson
3/4/5
Director
mixed-class rows
719,524
mixed-class rows
$3,978 27 Sep 2024
Vito J. Mangiardi
3/4/5
Director
mixed-class rows
299,377
mixed-class rows
$2,577 27 Mar 2024
Schumacher Richard T.
3/4/5
President, CEO, Director
mixed-class rows
1,281,428
mixed-class rows
$2,323 27 Sep 2024
Michael S. Urdea
3/4/5
Director
mixed-class rows
309,070
mixed-class rows
$1,332 27 Sep 2024
Alexander V Lazarev
3/4/5
Director
mixed-class rows
364,253
mixed-class rows
$1,047 27 Sep 2024
Edmund Y. Ting
3/4/5
Senior VP of Engineering
class O/S missing
326,853
18 Oct 2023

Recent Insider Transactions by Companies or Individuals for PRESSURE BIOSCIENCES INC

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .